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Does the Consumption of Green Tea Reduce the Risk of Lung Cancer
Among Smokers?
Wenbin Liang, Colin W. Binns, Le Jian and Andy H. Lee
School of Public Health, Curtin University of Technology, Perth, Australia
Experimental and epidemiological studies were reviewed to assess whether the consumption of green tea
could reduce the risk of lung cancer in smokers. Articles published since 1990 were located by searching
electronic databases PubMed, Ovid and Science Direct, using keywords ‘lung cancer’, ‘tea’ and
‘smoking’ without any restriction on language. After relevant articles had been located, further papers
were obtained from their reference lists. Evidence from experimental studies (in vitro animal and human
trials) suggested that regular intake of green tea may be protective against tobacco carcinogens.
However, the mechanism behind the protective effect is only partly understood. In most of the
epidemiological studies reviewed, the green tea exposure was within 5 years of the interview or follow-
up, which would coincide with the induction period and latent period of lung cancer. Longer term studies
are thus needed to further quantify the cancer risk. There is some evidence suggesting regular intake of
green tea at high level (>3 cups per day) may reduce the risk of smokers developing lung cancer.
Improvement in measuring green tea intake is required in order to confirm the evidence from
epidemiological studies.
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Introduction
Lung cancer has become one of the leading causes of death in
both developed and developing countries (1,2). Most of the
deaths from lung cancer are due to smoking tobacco products.
Worldwide in 2000, tobacco smoking contributed 77% of the
lung cancer deaths in males aged 30–69 years, and 82% in
males over 70 years (1,2). In 2003, for example, the prevalence
of smoking in China was estimated to be 58.9% among adult
males, while Chinese smokers are four times more likely to die
from lung cancer than non-smokers (3).
Although elimination of tobacco smoke exposure is the
obvious strategy to control lung cancer, no country has been
completely successful in implementing an effective inter-
vention. The efficacy of smoking cessation programs may
be enhanced if they are conducted in conjunction with other
complementary therapies. Epidemiological and experimental
studies have suggested that green tea may be protective
against cancer in different sites (4–21). In particular, recent
evidence from in vitro, animal and human trial studies
indicated the possibility that the consumption of green tea
may reduce the risk of lung cancer among smokers (2,22–
35), yet findings from epidemiological studies remained
inconsistent.
The aim of this review is to assess evidence from
experimental and epidemiological studies whether green tea
is a risk modifier for those exposed to tobacco smoke. The
focus is on the measurement of green tea exposure undertaken
in these studies.
Methods
Articles published since 1990 were located by searching
electronic databases PubMed, Ovid and Science Direct, using
keywords ‘lung cancer’, ‘tea’ and ‘smoking’ without any
restriction on language. After relevant articles had been
located, further papers were obtained from their reference
lists. A total of 78 relevant articles were eventually found.
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In vitro and Animal Studies
Both in vitro and animal studies have demonstrated that green
tea or tea polyphenols have a chemopreventive effect against
carcinogens from tobacco and is dependent on both the period
and dose of the exposure.
Period of exposure
The period of exposure to green tea or tea polyphenols and the
period of exposure to carcinogens must overlap. In one in vitro
study, green tea polyphenols were introduced once into the
living cell environment 2 h before exposing the cells to a
smoke solution for 30 min. Result showed that green tea
polyphenols can reduce DNA strand breakage induced by
cigarette smoke in cultured human bronchial cells A549 (32).
In another in vitro study, human lymphoid cells were exposed
to one single dose of green tea extracting solution 2 h before
adding benzo(a)pyrene-diol-epoxide (BPDE)—a metabolic
production of benzo(a)pyrene (B(a)P), which is a major
component of tobacco. The results demonstrated that green
tea can significantly reduce DNA damage caused by BPDE
(22). Similarly in four other animal studies (23,29,33,34), mice
were given green tea prior to or within 48 h of exposure to
tobacco carcinogens, and the green tea was continuously
administered for 16 weeks or 9 months. Other experimental
conditions such as diet, humidity, temperature and dark/light
cycle were controlled. Three out of the four studies found a
reduction in the incidence and the size of lung cancer tumors
due to drinking green tea (23,33,34).
Dose of exposure
The preventive effect of green tea is likely to be related to the
concentration of green tea as well as the dose of carcinogens.
In experimental studies both cells and animals were often
treated with relatively high doses of carcinogens and green tea.
For example, in a study which showed a protective effect of
green tea, the concentration of tobacco carcinogens used was
equivalent to the amount contained in the sidestream smoke
from one cigarette dissolved in 24 ml of water, while the
concentration of green tea polyphenol was set at 250 mgm l
 1,
corresponding to 116.5 mgm l
 1 of epigallocatechin-3-gallate
(EGCG) (32). Moreover, the bioavailability of different green
tea polyphenols has been a concern in animal and human
studies. Green tea polyphenols are not usually stable,
specifically, in water, EGCG can oxidize more than 50%
within 12 h, yet green tea used in experimental studies was
typically prepared every 48 h (33,34) to every 7 days (29).
In some studies where mice were exposed to both NNK [4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone] and green tea,
the NNK dosage administered was usually equal to that
experienced by a smoker in a lifetime (36). In one experiment
mice were randomized into different groups and given green
tea solution at concentrations of 0.2%, 0.4% and 0.6% as
drinking fluid 24 h after treating with NNK. Comparing with
the control group that drank only water, the protective effect of
green tea was only evident at the 0.6% concentration level
(33). In another study (29), mice were exposed to high levels of
environmental tobacco smoke for 5 months, while being given
1.25% green tea (2.5 g tea leave mixed with 200 ml boiling
water). The results indicated green tea had little effect on
reducing tumor incidence or multiplicity of the tumors.
However, none of the animals in the green tea treatment group
experienced early death while >10% of the mice in the control
group experienced early deaths, probably due to an overdose
of carcinogens exposure (29). Findings from these experiments
suggest that green tea may not be effective to inhibit the
formation or growth of lung tumor under high level of
carcinogens exposure and over a long duration.
Human Trials
Short-term effect
Because a single dose of green tea intake only produces a
short-term antioxidant effect, regular consumption seems
necessary. In a human study (37), 21 non-smokers consumed
300 ml of green tea solution or about three cups. Ferric
reducing ability of plasma (FRAP-assay) was used to
determine the antioxidant activity in plasma. The results of
this study showed that green tea consumption produced a
significant increase in antioxidant activity within 30–120 min
of exposure, but after 120 min the antioxidant activity
appeared to decrease. Another human trial with 10 healthy
subjects similarly found a short-term increase of plasma
antioxidant induced by drinking two to three cups of green tea
at one time (38). Such a short-term increase seemed to
correspond with the relatively short half-life of tea polyphe-
nols (30). In one pharmacokinetic study (39), 30 healthy
participants ingested 200 mg of EGCG equivalent to two cups
of green tea. Blood samples were collected at 0.5, 1, 2, 4, 6,
8 and 24 h after the EGCG administration. This experiment
found that the mean half-life of EGCG in plasma was only
118 min.
Protective effect from regular consumption
Regular green tea consumption could be protective over an
extended period. In one pilot study (35), three non-smokers
and three smokers (consumed more than 10 cigarettes per day)
drank two cups of green tea in the morning, two cups in the
afternoon and one cup at night daily for 4 weeks. Each cup of
green tea contained 400–500 mg of green tea extract. Oral
keratinocytes were harvested from each subject for analysis.
Outcomes included a reduction in smoking-induced DNA
damage, increased apoptosis and a further decrease in the
number of cells carrying damaged DNA (35). In a randomized
control trial (27), 133 smokers who smoked at least 10
cigarettes per day during the past year were randomized into
three groups consuming at least four cups daily of either
(i) decaffeinated green tea, (ii) decaffeinated black tea, or
18 Green tea and lung cancer risk among smokers(iii) water. After 4 months of intervention, smokers who drank
decaffeinated green tea had a significant decrease in their
urinary 8-hydroxydeoxyguanosine (8-OHdG) level, but no
significant changes were observed in both water and black tea
groups. Similar reduction in urinary 8-OHdG level was
observed among HbsAg positive volunteers who took daily
capsules containing green tea polyphenols equivalent to two to
four cups of tea for 3 months (40). In an intensive
observational study (25), the frequencies of sister-chromatid
exchange (SCE) in peripheral lymphocytes were measured as
markers of smoking-induced DNA damage. The frequencies of
SCE were significantly higher among smokers who were non-
tea drinkers, than those of non-smokers and smokers who
consumed green tea at least two to three cups per day during
the past 6 months. The differences between the latter two
groups, however, were not significant. It is possible that
consuming high levels of green tea over a long period may
reduce the DNA damage caused by tobacco smoking.
Lung tumor treatment
Only one clinical trial used green tea for treatment of lung
cancer (41). In this Phase I study, 17 advanced lung cancer
patients were given green tea extract at a single dose of
3gm
 2 ˙ per day for 4 weeks. The dosage equates to 20 cups of
green tea, which has been found to be the maximum tolerated
dose. Unfortunately, no effect of the treatment was observed.
Therefore, green tea is unlikely to be an effective cytotoxic
agent against existing tumor.
Limitation of human trials
Except two studies (27,40), most human intervention studies
involved small sample sizes generally less than 50 subjects. In
addition to ethical concerns, there were neither direct
measurement on the concentration of green tea polyphenols
in lung tissue nor on the change of lung tissue after green tea
exposure. Instead, the effects of green tea were measured by
the change in DNA damage and apoptosis of oral cells (35),
changes in biomarkers of DNA damage such as 8-OHdG and
SCE (25,27,40), and changes in plasma antioxidant capacity
(30,37,38). Trials with sufficient sample size and longer period
of follow-up are needed to confirm the protective effect of
green tea.
Mechanisms Based on Experimental Studies
As shown in Fig. 1, carcinogens contained in cigarette smoke
are activated by Phase I enzymes in the body, leading to the
formation of DNA adducts (36). If DNA adducts escape
cellular repair mechanisms, it may result in miscoding and
eventually a stable mutation. Blocking any step in the pathway
would reduce the incidence of lung cancer among smokers
(36). Table 1 provides the possible mechanisms of chemopre-
vention effect of green tea. The evidence suggested that
catechins in green tea, especially EGCG, may prevent the
formation of a mutated cell.
In both animal and in vitro studies, green tea was found to
increase the activities of Phase II enzymes (2,8,28,31). Phase II
Figure 1. Mechanism of tobacco carcinogens inducing lung cancer.
Table 1. Possible mechanism of action
Possible mechanism of chemoprevention
effect of green tea
References
Acting as antioxidant to prevent DNA
damage and reduce the formation
of DNA adducts
(11,22,25,27,35,40)
Increasing apoptosis and preventing the
persistence of miscoding DNA (possibly
by inducing gene regulation)
(11,26,31,33,35,40,43,44)
Activating Phase II detoxifying enzymes,
and increasing the excretion of carcinogens
(possibly by inducing gene regulation)
(2,8,28,31)
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subsequent excretion (42). The amount of carcinogens that
may be further activated, as well as DNA adducts, are thus
reduced. The antioxidant properties of green tea have alsobeen
demonstrated in trials involving smokers. It reduced the urine
concentration of 8-OHdG, a strong biomarker of DNA damage
(27). Moreover, green tea extract could inhibit the formation of
human DNA adducts (11,22,35).
Once carcinogen DNA adducts have formed, persistent
mutation is likely unless cells with DNA adducts are removed
by apoptosis (36). Human (35), animal (11,33) and in vitro
studies (26,43,44) have shown that green tea can induce
apoptosis among injured cells exposed to carcinogens from
tobacco smoke. However, smoking may be regarded as a
chronic exposure, since long duration of tobacco smoking has
greater impact on lung caner risk than the amount smoked per
day (45). Therefore, a long exposure to green tea is needed in
order to reduce the damage caused by tobacco carcinogens.
Epidemiological Studies
Induction time and latent period of lung carcinoma
Latent period refers to the time between disease occurrence
and detection, while tumor induction time commences when
the effect of the exposure occurs until all of the component
causes involved in one sufficient cause are satisfied—the time
of disease occurrence (46). Exposure within the induction and
latent periods is irrelevant to the formation of a tumor (47).
Moreover, the incidence of lung cancer does not appear to be
lower among ex-smokers who quit smoking within 5 years
than current smokers (48,49). This indicates that the sum of
induction period and latent period of lung cancer caused by
tobacco smoking may be longer than 5 years. Logically, no
reduction in incidence of lung carcinoma is expected among
current smokers who drink green tea for 5 years prior to the
calculation of incidence, regardless of their consumption level.
Measurement of green tea exposure and other limitations
Table 2 summarizes epidemiological studies on tea and lung
cancer. Three case–control studies (50–52) found a signifi-
cantly lower risk of lung cancer among non-smokers with a
high consumption of green or black tea, but no protective
effect was evident among smokers (50,51). However, the
period of tea consumption referred to 5 years or less before the
diagnosis or interview. Although the subjects might have been
drinking tea for a long time, the duration and quantity of tea
consumption was not assessed, so the effect of green tea could
not be fully justified. Cohort studies, on the other hand, were
based on information of tea consumption at the beginning
of the study (53–55) and suggested that tea consumption
increased with age (54,55). In particular, the Japanese study
(53) with a long follow-up period of 14 years showed that
people consuming green tea two to four times per day had
a relative risk of 0.78 (95% CI ¼ 0.6–1.0), when compared
with those drinking once or less per day and after adjustment
for potential confounders. But for subjects drinking green
tea more than five times per day, the relative risk was only
0.79 (95% CI ¼ 0.59–1.1), the non-significance result
probably due to insufficient sample size at this high level of
consumption (53).
In summary, there is only limited evidence from epi-
demiological studies that green tea is protective against lung
cancer among smokers. Moreover, green tea exposure was
generally taken to be within 5 years of interview or follow-up,
which would have little impact on the incidence of lung
cancer.
Table 2. Epidemiology studies on tea and lung cancer
Country Study design Sample size Tea type and highest
consumption level
Reference period
of intake
Smoking status
of subjects
Results
China (50) Population-based
case–control study
Cases: 649
Controls: 675
Green tea: >1500 g
tea leaves per year
5 years before interview Smokers and
non-smokers
OR ¼ 0.65; 95%
CI ¼ 0.45–0.93 for
non-smokers
OR ¼ 0.94;
95% CI ¼ 0.40–2.22
for smokers
Canada (52) Population-based
case–control study
Cases: 582
Controls: 582
Type unspecified:
>7 cups per day
2 years before study Non-smokers OR ¼ 0.4; 95%
CI ¼ 02–0.7
USA (51) Population based
case–control study
Cases: 161
Controls 483
Green tea:
>1 cup per day
1 year before diagnosis
or interview
Smokers and
non-smokers
OR ¼ 0.9; 95%
CI ¼ 0.5–1.6
Japan (53) Cohort study
(1980–94)
Subjects: 38 540
Person-years at risk:
unspecified
Cases: 436
Green tea:
>5 times per day
Unspecified; survey taken
at start of study
Smokers and
non-smokers
RR ¼ 0.78; 95%
CI ¼ 0.6–1.0 for
people drinking tea
2–4 times per day
Japan (54) Cohort study
(1986–95)
Subjects: 8552
Person-years at
risk: 71 248.5
Cases: 384
Green tea:
>10 cups per day
Unspecified; survey taken at
start of study
Smokers and
non-smokers
Cancer in all sites
RR ¼ 0.68 for males;
95% CI ¼ 0.39–1.21
RR ¼ 0.57 for females;
95% CI ¼ 0.33–0.98
OR, odds ratio; RR, relative risk; CI, confidence interval.
20 Green tea and lung cancer risk among smokersConclusion
Our review suggests that regular intake of green tea at high
levels (>3 cups per day) may offer protection against tobacco
carcinogens for smokers, provided that the duration of green
tea consumption is sufficiently long to cover the smoking
period. For epidemiology studies, improvement in measuring
green tea intake is required in order to confirm the chemo-
preventive effect of green tea observed in in vitro animal and
human trials.
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